Home
Journal Issues
Current Issue
All Issues
In Progress
Contact Us
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
3080-0382
Biomed adv
. 2026;3(1): 3-9. doi:
10.34172/bma.62
Review Article
Personalized neoantigen vaccines in melanoma: Current workflow and adjuvant opportunities
Behzad Mansoori
1
, Mohsen Mohammadi
2
*
Cited by CrossRef:
1- Mhanna D, Salman B, El Hakim R, Aridi L, Abou Ali W, Al Halabi B, Faour V, Harb F, Azar S, Ghadieh H. Therapeutic melanoma vaccines: Platforms, neoantigen strategies, and emerging combination immunotherapies.
Therapeutic Advances in Vaccines and Immunotherapy
. 2026;14
[Crossref]
Submit Your Paper
Editorial Board
Editorial Policies
Aims and Scope
For Authors
Archive
Acceptance Rate:
35%
Submission to First Decision:
20 Days
Received to Acceptance:
60 Days
Acceptance to Publication:
40 Days
*
Average article statistics from the last 12 months of data.
In
collaboration with